Allot Ltd. ALLT is scheduled to report its first-quarter 2025 results on May 12, before the bell. ALLT’s Q1 Expectations Despite signs of a turnaround, the company may face headwinds that could weigh on both revenue and earnings. One major concern is the timing of deals and associated revenue recognition. In the fourth quarter of 2024, Allot posted a sharp 55% year-over-year decline in product revenues, largely due to delays in deal closures and when revenues were able to be officially recorded. If these timing challenges continue into the first quarter, the financials could once again reflect suppressed top-line performance, even if demand remains steady in the longer term. The Zacks Consensus Estimate for Allot’s revenues in the first quarter of 2025 is pegged at $20.2 million, implying a 7.7% year-over-year decline. Loss per share is pegged at 5 cents compared with a year-ago loss of 3 cents per share. Allot Ltd. Price and EPS Surprise Allot Ltd. price-eps-surprise | Allot Ltd. Quote What Our Model Says About Allot Our proven model does not conclusively predict an earnings beat for ALLT this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter. Allot currently has an Earnings ESP of 0.00% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here. Recent Earnings of Some Service Givers Equifax Inc. EFX reported impressive first-quarter 2025 results. EFX’s adjusted earnings were $1.53 per share, outpacing the Zacks Consensus Estimate by 9.3% and increasing 2% from the year-ago quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Total revenues of $1.4 billion surpassed the consensus estimate by 1.9% and grew 3.6% on a year-over-year basis. Fiserv, Inc. FI has reported mixed first-quarter 2025 results. FI’s adjusted earnings per share of $2.14 beat the consensus mark by 2.9% and gained 13.8% year over year. Adjusted revenues of $4.8 billion missed the consensus estimate by 1.6% but gained 5.5% on a year-over-year basis. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Equifax, Inc. (EFX):Free Stock Analysis Report Allot Ltd. (ALLT):Free Stock Analysis Report Fiserv, Inc. (FI):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Allot to Report Q1 Earnings: What's in the Offing for the Stock?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...